Improved Reperfusion and Neuroprotection by Creatine in a Mouse Model of Stroke
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Stroke leads to energy failure and subsequent neuronal cell loss. Creatine and phosphocreatine constitute a cellular energy buffering and transport system, and dietary creatine supplementation was shown to protect neurons in several models of neurodegeneration. Although creatine has recently been found to reduce infarct size after cerebral ischemia in mice, the mechanisms of neuroprotection remained unclear. We provide evidence for augmented cerebral blood flow (CBF) after stroke in creatine-treated mice using a magnetic resonance imaging (MRI)-based technique of CBF measurement (flow-sensitive alternating inversion recovery-MRI). Moreover, improved vasodilatory responses were detected in isolated middle cerebral arteries obtained from creatine-treated animals. After 3 weeks of dietary creatine supplementation, minor changes in brain creatine, phosphocreatine, adenosine triphosphate, adenosine diphosphate and adenosine monophosphate levels were detected, which did not reach statistical significance. However, we found a 40% reduction in infarct volume after transient focal cerebral ischemia. Our data suggest that creatine-mediated neuroprotection can occur independent of changes in the bioenergetic status of brain tissue, but may involve improved cerebrovascular function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is evidence from animal models that creatine supplementation is neuroprotective [147–149] and can reduce the severity of spinal cord injury [150, 151], cerebral ischemia [152–155], and concussion/traumatic brain injury [2, 7, 12, 22, 32, 33, 156].”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [152]
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Self-citationDetre, J. A., Leigh, J. S., Williams, D. S., & Koretsky, A. P. (1992) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910230106 · Cited by 1,571
Use of MTT colorimetric assay to measure cell activation
Gerlier, D., & Thomasset, N. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90215-2 · Cited by 1,197
Kim, S. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910340303 · Cited by 1,001
What is the Correct Value for the Brain-Blood Partition Coefficient for Water?
Herscovitch, P., & Raichle, M. E. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.9 · Cited by 705
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., & Meisel, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10291.2002 · Cited by 462
Self-citationNeuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease
Matthews, R. T., Yang, L., Jenkins, B. G., Ferrante, R. J., Rosen, B. R., Kaddurah-Daouk, R., & Beal, M. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00156.1998 · Cited by 430
Research works printed but not linked: 1
- Reid JM, 1996, Am J Physiol, 270, H45
Cited by
Items 101–128 of 128
Santacruz, L., Darrabie, M. D., Mishra, R., & Jacobs, D. O. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430359 · Cited by 6
Creatine Amides: Perspectives for Neuroprotection
Vlasov, T. D., Чефу, С. Г., Baisa, A. E., Leko, M. V., Burov, S. V., & Веселкина, О. С. (2013) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-013-9756-6 · Cited by 4
Cerebral Perfusion MRI in Mice
Kober, F., Duhamel, G., & Callot, V. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-219-9_6 · Cited by 3
Physiological Basis for Creatine Supplementation in Skeletal Muscle and the Central Nervous System
Kraemer, W. J., Beeler, M. K., Post, E. M., Luk, H., Lombard, J. R., Dunn‐Lewis, C., & Volek, J. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813922-6.00049-7 · Cited by 4
Neto, A. A. M., Neto, A. F., Moreira, F. M. D. R., Rigopoulos, L., Tsunemi, D., & Soufen, M. A. (2021) · Acta Cirúrgica Brasileira · doi:10.1590/acb360305 · Cited by 2
Yuluğ, B., Velioğlu, H. A., Sayman, D., Hanoğlu, L., Akan, G. E., & Çankaya, Ş. (2023) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.28420 · Cited by 2
Liang, J., Zheng, P., Hu, J., Liu, X., Chen, K., Cao, Y., Liang, Y., Lu, C., Xie, J., Ma, Y., et al. (2025) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073335304241023153906 · Cited by 2
Neuroprotective Agents in Glaucoma
Bagli, E., & Kitsos, G. (2011) · InTech eBooks · doi:10.5772/19067 · Cited by 4
Cytoprotective Actions of Creamide in Experimental Cerebral Ischemia/Reperfusion in Rats
Веселкина, О. С., Nv, K., Kolpakova, M. E., Чефу, С. Г., & Vlasov, T. D. (2014) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-014-9951-0 · Cited by 1
Liu, F., Song, X., Zhang, H., Li, Y., & Zhang, X.-F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05015-z · Cited by 1
Weir, J. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-573-2_6 · Cited by 1
Chun, J., Liu, Y., Kibler, G. L., Lee, H., Babakhani, K., Rhoades, N., Bivins, I., Ko, J., Dickerson, B., Gonzalez, D. E., et al. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2716273
Time-course study of high-dose creatine supplementation for endogenous creatine synthesis
Xiang, M., Harbige, L. S., Li, X., Li, B., & Ai, H. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108006897
Creatine and Exercise - Strong Evidence for Stronger Heart Muscle?
Webster, I., Huisamen, B., & Toit, E. F. D. (2011) · Griffith Research Online · Cited by 1
MODELS, BIOLOGICAL Study of renal and hepatic toxicity in rats supplemented with creatine 1
Cesar, N., & de Castro, L. P. (2015)
O envolvimento de proteínas quinases na facilitação do aprendizado espacial induzido por creatina
Souza, M. A. (2009) · Americanae (AECID Library)
A Review Of Creatine And Its Role In Muscle Strength And Balance
Albl, A. A. (2018) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · doi:10.71889/5fylantbak.29862935
Aspectos e efeitos da creatina sobre o sistema renal e hepático
de Souza, W. M. (2019) · Revista Brasileira de Fisiologia do Exercício · doi:10.33233/rbfe.v9i3.3535
From Gym to Medicine: Creatine Uses Beyond Athletic Performance
Sikora, M., Iskrzyński, D., Gugulski, H., & Suchy, W. (2024) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/rrrbombiya
Bury, A., Biesaga, P., Kotte, K., Jadanowski, O., Łebek, K., Sobota, W., Piskorz, P., Litworska-Sójka, D., Komsta, B., & Lipiec, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3546 · Cited by 1
Creatine supplementation for brain metabolic stress: a narrative review
Candow, D. G., Moriarty, T. A., Wong, S., Fabiano, N., Forbes, S. C., & Kerksick, C. M. (2026) · Academia Neuroscience and Brain Research · doi:10.20935/acadneurosci8345
Creatine Uncovered: Expanding Its Role from Fitness Supplement to Therapeutic Agent
Gonzalez, M., & Ruiz, J. (2024) · Journal of Applied Pharmaceutical Technologies and Systems · doi:10.68159/i981004315
Chun, J., Babakhani, K., Gonzalez, D. E., Dickerson, B. L., Sowinski, R. J., Rasmussen, C. J., & Kreider, R. B. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2711032 · Cited by 2
Machado, M. (2026) · Experimental Physiology · doi:10.1113/ep094109 · Cited by 1
Effects of Metabolic Risk Factors and Type 1 Diabetes on Brain Glucose and Brain Metabolites
Heikkilä, O. (2010) · Helda - University of Helsinki Institutional Repository
Webster, I. (2010) · SUNScholar (Stellenbosch University)
Metadata
- Authors
- Prass, K., Royl, G., Lindauer, U., Freyer, D., Megow, D., Dirnagl, U., Stöckler-Ipsiroglu, G., Wallimann, T., & Priller, J.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- University of Vienna (AT)
- ETH Zurich (CH)
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2007-03
- Volume
- 27
- Issue
- 3
- Pages
- 452-459
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- OpenAlex
- W2026671178
- Cited by
- 128
- References
- 39
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 7 · 2014: 7 · 2013: 8 · 2012: 5
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- creatine, neuroprotection, stroke, cerebral ischemia, reperfusion, cerebral blood flow, vasodilation, middle cerebral artery, infarct size, brain energy metabolism, phosphocreatine, adenosine nucleotides, dietary supplementation, focal cerebral ischemia
- MeSH terms
- Adenosine Triphosphate, Animals, Brain, Brain Ischemia, Cerebrovascular Circulation, Creatine, Disease Models, Animal, Magnetic Resonance Imaging, Male, Phosphocreatine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.